Natera
Natera is seeking an Associate Director of Strategic Program Management to lead IVD and companion diagnostic programs from development planning through PMA submission. This role involves shaping development strategy, driving integrated execution across multiple functions, and presenting recommendations to the Executive Leadership Team. The position requires leading complex programs, resolving competing priorities, and ensuring submission readiness without direct authority.
Headquarters
Austin, Texas, United States
Company Size
1001-5000 employees
Founded
2004
Natera is a molecular diagnostics company that develops and commercializes cell-free DNA testing for oncology, women's health, organ health, and rare disease. Its tests are used for cancer detection and monitoring, noninvasive prenatal and carrier screening, transplant rejection assessment, and genomic analysis for rare diseases. Natera's clinically validated tests are processed in CAP/CLIA-certified labs and supported by over 400 peer-reviewed publications.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Natera.
Natera's 1.18% Stock Decline Despite $280M Volume Surge Ranks 429th in Trading Activity
14 hours ago
Regulatory
Precede Biosciences
Associate Director, Companion Diagnostic (CDx) Strategy and Development
Regeneron Pharmaceuticals
FDA Regulatory Attorney – Class III IVD / Companion Diagnostics
Axiom
Senior Manager, Clinical Diagnostics
Regeneron Pharmaceuticals
Associate Director, Companion Diagnostic (CDx) Strategy and Development
Regeneron Pharmaceuticals
Staff Scientist, IVD Assay Verification and Validation
DELFI Diagnostics, Inc.